Nonmotor symptoms in Parkinson's disease: expanding the view of Parkinson's disease beyond a pure motor, pure dopaminergic problem

Neurol Clin. 2013 Aug;31(3 Suppl):S1-16. doi: 10.1016/j.ncl.2013.04.013. Epub 2013 Jun 14.

Abstract

Nonmotor symptoms (NMS) of Parkinson's disease (PD) are critical to identify and treat because of their impact on quality of life. Despite growing evidence of the importance of NMS on patients' quality of life, gaps remain in their recognition and treatment. The result is a need for increased information and understanding of specific NMS and the clinical approaches for their assessment and management in the context of PD as a whole. This article discusses the NMS of PD, their relationship to the pathologic basis of PD, and how NMS can be best managed.

Keywords: Dopaminergic; Motor symptoms; Nonmotor symptoms; Parkinson's disease.

Publication types

  • Review

MeSH terms

  • Animals
  • Cognition Disorders / diagnosis
  • Cognition Disorders / drug therapy
  • Cognition Disorders / psychology
  • Dopamine / metabolism
  • Dopamine Agents / therapeutic use*
  • Humans
  • Mental Disorders / diagnosis
  • Mental Disorders / drug therapy
  • Mental Disorders / psychology
  • Parkinson Disease / diagnosis*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / psychology*
  • Quality of Life / psychology*
  • Sleep Wake Disorders / diagnosis
  • Sleep Wake Disorders / drug therapy
  • Sleep Wake Disorders / psychology

Substances

  • Dopamine Agents
  • Dopamine